Package Leaflet: Information for the User
Xarelto 15mg film-coated tablets
Xarelto 20mg film-coated tablets
rivaroxaban
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Xarelto contains the active substance rivaroxaban.
Xarelto is used in adults to:
Xarelto is used in children and adolescents under 18 years of age and with a body weight of 30 kg or more to:
Xarelto belongs to a group of medicines called antithrombotic agents. It works by blocking a factor in the blood that is involved in blood clotting (factor Xa), and thus reduces the tendency of the blood to form clots.
Do not take Xarelto
Do not take Xarelto and inform your doctorif any of these apply to you.
Warnings and precautions
Talk to your doctor or pharmacist before taking Xarelto.
Be careful with Xarelto
Tell your doctorif you have any of these conditionsbefore taking Xarelto. Your doctor will decide if you should be treated with this medicine and if you should be kept under closer observation.
If you need to have surgery
Children and adolescents
Xarelto tablets are not recommended in children with a body weight below 30kg.
There is not enough information about the use of Xarelto in children and adolescents for the indications in adults.
Other medicines and Xarelto
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including those obtained without a prescription.
If any of the above applies to you, tell your doctorbefore taking Xarelto, as the effect of Xarelto may be increased. Your doctor will decide if you should be treated with this medicine and if you should be kept under closer observation.
If your doctor considers that you have a higher risk of developing a stomach or intestinal ulcer, he may recommend that you also take a preventive treatment.
If any of the above applies to you,tell your doctorbefore taking Xarelto, as the effect of Xarelto may be reduced. Your doctor will decide if you should be treated with this medicine and if you should be kept under closer observation.
Pregnancy and breast-feeding
Do not take Xarelto if you are pregnant or breast-feeding. If there is a possibility that you may become pregnant, use a reliable contraceptive while taking Xarelto. If you become pregnant while taking this medicine, tell your doctor immediately, who will decide how you should be treated.
Driving and using machines
Xarelto may cause dizziness (common side effect) or fainting (uncommon side effect) (see section 4 "Possible side effects"). You should not drive, ride a bicycle or use tools or machines if you are affected by these symptoms.
Xarelto contains lactose and sodium
If your doctor has told you that you have an intolerance to some sugars, consult him before taking this medicine.
This medicine contains less than 1 mmol of sodium (23 mg) per tablet; this is, essentially "sodium-free".
Take this medicine exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist.
You must take Xarelto with food.
Swallow the tablets, preferably with water.
If you have difficulty swallowing the tablet whole, ask your doctor about other ways to take Xarelto. The tablet can be crushed and mixed with water or apple puree, immediately before taking it. Then take food.
If necessary, your doctor may also administer the crushed Xarelto tablet through a gastric tube.
What dose to take
The recommended dose is one Xarelto 20 mg tablet once a day.
If you have kidney problems, the dose may be reduced to one Xarelto 15 mg tablet once a day.
If you need to undergo a procedure to treat blocked blood vessels in your heart (called percutaneous coronary intervention - PCI with stent placement), there is limited evidence to reduce the dose to one Xarelto 15 mg tablet once a day (or one Xarelto 10 mg tablet once a day if your kidneys do not work properly) in addition to an antiplatelet medicine such as clopidogrel.
The recommended dose is one Xarelto 15 mg tablet twice a day for the first 3 weeks. For treatment after 3 weeks, the recommended dose is one Xarelto 20 mg tablet once a day.
After at least 6 months of treatment for blood clots, your doctor may decide to continue treatment with one Xarelto 10 mg tablet once a day or one Xarelto 20 mg tablet once a day.
If you have kidney problems and are taking one Xarelto 20 mg tablet once a day, your doctor may decide to reduce the treatment dose to one Xarelto 15 mg tablet once a day after 3 weeks if the risk of bleeding is higher than the risk of having another blood clot.
The dose of Xarelto depends on body weight and will be calculated by your doctor.
Take each dose of Xarelto with a drink (e.g. water or juice) during a meal. Take the tablets every day at approximately the same time. Consider setting an alarm to remind you.
For parents or caregivers: watch the child to make sure they take the entire dose.
Since the dose of Xarelto is based on body weight, it is important to attend scheduled visits with your doctor, as it may be necessary to adjust the dose as weight changes.
Never adjust the dose of Xarelto on your own. Your doctor will adjust the dose if necessary.
Do not split the tablet to try to get a fraction of the tablet dose. If a smaller dose is required, please use the alternative Xarelto granule presentation for oral suspension.
In children and adolescents who cannot swallow whole tablets, please use Xarelto granules for oral suspension.
If the oral suspension is not available, you can crush the Xarelto tablet and mix it with water or apple puree immediately before taking it. Take some food after taking this mixture. If necessary, your doctor may also administer the crushed Xarelto tablet through a gastric tube.
If you spit up the dose or vomit
Call your doctor if you spit up the dose or vomit repeatedly after taking Xarelto.
When to take Xarelto
Take the tablets every day, until your doctor tells you to stop.
Try to take the tablets at the same time every day to remember when to take them.
Your doctor will decide how long you should continue taking the treatment.
To prevent the formation of blood clots in the brain (stroke) or in other blood vessels:
If it is necessary to normalize your heartbeat through a procedure called cardioversion, take Xarelto at the times your doctor has indicated.
If you forget to take Xarelto
If you are taking one 20 mg or one 15 mg tablet oncea day, and you forget a dose, take it as soon as you remember. Do not take more than one tablet in one day to make up for a forgotten dose. Take the next tablet the next day and then continue taking one tablet every day.
If you are taking one 15 mg tablet twicea day, and you forget a dose, take it as soon as you remember. Do not take more than two 15 mg tablets in one day. If you forget a dose, you can take two 15 mg tablets at the same time, for a total of two tablets (30 mg) in one day. The next day, you should continue taking one 15 mg tablet twice a day.
If you take more Xarelto than you should
Call your doctor immediately if you have taken too many Xarelto tablets. Taking too much Xarelto increases the risk of bleeding.
If you stop taking Xarelto
Do not stop taking Xarelto without first talking to your doctor, as Xarelto treats and prevents serious conditions.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, Xarelto can cause adverse effects, although not all people suffer from them.
Like other similar medicines to reduce blood clot formation, Xarelto can cause bleeding that can put the patient's life at risk. Excessive bleeding can cause a sudden drop in blood pressure (shock). In some cases, the bleeding may not be evident.
Inform your doctor immediately if you experience any of the following symptoms:
Your doctor may decide to keep you under closer observation or change your treatment.
The frequency of these adverse effects is very rare (up to 1 in 10,000 people).
The frequencies of severe allergic reactions are very rare (anaphylactic reactions, including anaphylactic shock; may affect up to 1 in 10,000 people) and uncommon (angioedema and allergic edema; may affect up to 1 in 100 people).
General list of possible adverse effects found in adults, children, and adolescents
Frequent(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Very Rare(may affect up to 1 in 10,000 people)
Frequency Not Known(frequency cannot be estimated from available data)
Adverse Effects in Children and Adolescents
In general, the adverse effects observed in children and adolescents treated with Xarelto were similar to those observed in adults and their severity was mainly mild to moderate.
Adverse effects that were more frequently observed in children and adolescents:
Very Frequent(may affect more than 1 in 10 people)
Frequent(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Reporting of Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that is not listed in this leaflet. You can also report them directly through the national reporting system included in Appendix V. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date that appears on the packaging and on each blister or bottle after "EXP" or "CAD".
The expiration date is the last day of the month indicated.
No special storage conditions are required.
Crushed tablets
Crushed tablets are stable in water or apple puree for up to 4 hours.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of the packaging and medicines that are no longer needed. This will help protect the environment.
Xarelto Composition
Tablet core: microcrystalline cellulose, sodium croscarmellose, lactose monohydrate, hypromellose (2910), sodium lauryl sulfate, magnesium stearate. See section 2 "Xarelto contains lactose and sodium"
Tablet film coating: macrogol (3350), hypromellose (2910), titanium dioxide (E 171), red iron oxide (E 172).
Product Appearance and Package Contents
The Xarelto 15 mg film-coated tablets are round, red, biconvex, and bear the Bayer cross on one side, and "15" and a triangle on the other.
They are packaged
The Xarelto 20 mg film-coated tablets are round, brown-red, biconvex, and bear the Bayer cross on one side, and "20" and a triangle on the other.
They are packaged
Not all pack sizes may be marketed.
Marketing Authorization Holder
Bayer AG
51368 Leverkusen
Germany
Manufacturer
The manufacturer can be identified by the batch number printed on the side flap of the pack and on each blister or bottle:
Bayer AG
Kaiser-Wilhelm-Allee
51368 Leverkusen
Germany
Bayer HealthCare Manufacturing Srl.
Via delle Groane, 126
20024 Garbagnate Milanese
Italy
Bayer Bitterfeld GmbH
Ortsteil Greppin, Salegaster Chaussee 1
06803 Bitterfeld-Wolfen
Germany
You can request more information about this medicine by contacting the local representative of the marketing authorization holder:
België / Belgique / Belgien Bayer SA-NV Tel: +32-(0)2-535 63 11 | Lietuva UAB Bayer Tel: +370-5-233 68 68 |
???????? ????? ???????? ???? ???: +359-(0)2-424 72 80 | Luxembourg / Luxemburg Bayer SA-NV Tel: +32-(0)2-535 63 11 |
Ceská republika Bayer s.r.o. Tel: +420-266 101 111 | Magyarország Bayer Hungária KFT Tel: +36-1-487 4100 |
Danmark Bayer A/S Tlf: +45-45 235 000 | Malta Alfred Gera and Sons Ltd. Tel: +356-21 44 62 05 |
Deutschland Bayer Vital GmbH Tel: +49-(0)214-30 513 48 | Nederland Bayer B.V. Tel: +31–(0)297-28 06 66 |
Eesti Bayer OÜ Tel: +372-655 85 65 | Norge Bayer AS Tlf: +47-23 13 05 00 |
Ελλ?δα Bayer Ελλ?ς ΑΒΕΕ Τηλ: +30-210-618 75 00 | Österreich Bayer Austria Ges. m. b. H. Tel: +43-(0)1-711 460 |
España Bayer Hispania S.L. Tel: +34-93-495 65 00 | Polska Bayer Sp. z o.o. Tel: +48-22-572 35 00 |
France Bayer HealthCare Tél (N° vert): +33-(0)800 87 54 54 | Portugal Bayer Portugal, Lda. Tel: +351-21-416 42 00 |
Hrvatska Bayer d.o.o. Tel: + 385-(0)1-6599 900 | România SC Bayer SRL Tel: +40-(0)21-528 59 00 |
Ireland Bayer Limited Tel: +353 1 216 3300 | Slovenija Bayer d. o. o. Tel: +386-(0)1-58 14 400 |
Ísland Icepharma hf. Sími: +354-540 80 00 | Slovenská republika Bayer, spol. s r.o. Tel: +421-(0)2-59 21 31 11 |
Italia Bayer S.p.A. Tel: +39-02-3978 1 | Suomi/Finland Bayer Oy Puh/Tel: +358-(0)20-78521 |
Κ?προς NOVAGEM Limited Τηλ: +357-22-48 38 58 | Sverige Bayer AB Tel: +46-(0)8-580 223 00 |
Latvija SIA Bayer Tel: +371-67 84 55 63 | United Kingdom Bayer plc Tel: +44-(0)118 206 3000 |
Date of Last Revision of this Leaflet:
Detailed information on this medicine is available on the European Medicines Agency website http://www.ema.europa.eu.